Summary & Overview
CPT 88371: Western Blot Protein Analysis of Tissue
CPT code 88371 denotes a Western blot protein analysis performed on tissue specimens (commonly muscle tissue), with interpretation and reporting included. This laboratory pathology code is nationally relevant because Western blot testing is a specialized diagnostic technique used in neuromuscular and other tissue-based disease evaluations. Accurate coding affects clinical documentation, lab workflow, and payer adjudication across commercial and federal payers.
Key payers covered in this analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. The publication provides benchmarks for utilization and payment patterns, clarifies clinical context for when tissue Western blotting is used, and summarizes relevant policy considerations affecting coverage and billing practices.
Readers will learn the clinical purpose of CPT code 88371, typical sites of service, common billing modifiers (listed separately), and where to find related laboratory service codes. The document highlights areas where coding clarity matters for laboratory reporting, payer coverage decisions, and downstream clinical interpretation. Data not available in the input are noted where applicable.
Billing Code Overview
CPT code 88371 describes a protein analysis of tissue using the Western blot method, typically performed by a clinical laboratory analyst. The code includes interpretation and a written report of the test findings.
Service type: Laboratory — molecular/protein diagnostic analysis
Typical site of service: Clinical laboratory or hospital pathology laboratory, commonly performed on tissue specimens such as muscle tissue.
Clinical & Coding Specifications
Clinical Context
A 32-year-old patient presents with progressive proximal muscle weakness, myalgias, and elevated serum creatine kinase. The neurologist performs a muscle biopsy to evaluate for inflammatory myopathy or a suspected muscular dystrophy. Tissue is submitted to the pathology laboratory where an analyst performs a protein analysis using the Western blot method (88371). The laboratory receives fresh-frozen or properly preserved muscle tissue, isolates protein, runs SDS-PAGE, transfers to membrane, probes with specific antibodies (for example, dystrophin or sarcoglycan panels), and documents band patterns. The report includes interpretation correlating detected protein abnormalities with suspected diagnoses (e.g., dystrophin deficiency in Duchenne/Becker muscular dystrophy or loss of specific proteins in limb-girdle muscular dystrophy). Typical workflow steps: surgical biopsy → specimen transport and accessioning → tissue preparation and protein extraction → Western blot assay and controls → interpretation and reporting → archival of raw data and report in the medical record. Typical site of service: hospital-based outpatient surgical suite, ambulatory surgery center, or hospital inpatient setting with specimen processing in a clinical pathology laboratory.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
26 | Professional component | Use when billing only the professional component of the test report by a physician or qualified pathologist. |